(Q53520146)

15 May 2018

title

Doxycycline influences microcirculation patterns in B16 melanoma. (English)

1 reference

15 May 2018

1 reference

Baocun Sun

1

1 reference

15 May 2018

Shiwu Zhang

2

1 reference

15 May 2018

Danfang Zhang

3

1 reference

15 May 2018

Xiaojin Yin

4

1 reference

15 May 2018

Sen Wang

5

1 reference

15 May 2018

Yanjun Gu

6

1 reference

15 May 2018

Yalei Wang

7

1 reference

15 May 2018

publication date

1 November 2007

1 reference

15 May 2018

Experimental Biology and Medicine

published in

1 reference

15 May 2018

volume

232

1 reference

15 May 2018

issue

10

1 reference

15 May 2018

page(s)

1300-1307

1 reference

15 May 2018

Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry

cites work

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

Expression of activated Akt and PTEN in malignant melanomas: relationship with clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

Vasculogenic mimicry and tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

Antagonists to human and mouse vascular endothelial growth factor receptor 2 generated by directed protein evolution in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

A novel strategy for the tumor angiogenesis-targeted gene therapy: generation of angiostatin from endogenous plasminogen by protease gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

CMT-3, a non-antimicrobial tetracycline (TC), inhibits MT1-MMP activity: relevance to cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

Minocycline-induced pigmentation. Incidence, prevention and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

Matrix metalloproteinases: biologic activity and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

High affinity binding of latent matrix metalloproteinase-9 to the alpha2(IV) chain of collagen IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

Inflammatory breast cancer: vasculogenic mimicry and its hemodynamics of an inflammatory breast cancer xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

Molecular determinants of ovarian cancer plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

Remodeling of the microenvironment by aggressive melanoma tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

Endothelial signaling during development

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

Doxycycline inhibits cell proliferation and invasive potential: combination therapy with cyclooxygenase-2 inhibitor in human colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

Effects of minocycline and doxycycline on cell survival and gene expression in human gingival and periodontal ligament cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

Effects of Angiogenesis Inhibitors on Vascular Network Formation by Human Endothelial and Melanoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0705-RM-145

21 January 2018

Identifiers

DOI

10.3181/0705-RM-145

1 reference

15 May 2018

PubMed ID

17959842

1 reference

15 May 2018